PHARMACOLOGICAL SUPPORT ORGANIZATION OF ТВ PATIENTS IN SMOLENSK REGION

PHARMACOLOGICAL SUPPORT ORGANIZATION OF ТВ PATIENTS IN SMOLENSK REGION

The article reflects the features of pharmacological support of tuberculosis patients in Smolensk oblast. The participants of the process are described: the subjects of management, funding, pharmacological support. The differences between funding systems of 2008 and 2012 were characterized.

Bibliographic Details
Main Authors:	N. A. Pavluchenkova, A. V. Krikova, E. A. Sakharitova
Format:	Article
Language:	Russian
Published:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2015-09-01
Series:	Фармация и фармакология (Пятигорск)
Subjects:	туберкулез лекарственное обеспечение финансирование
Online Access:	https://www.pharmpharm.ru/jour/article/view/119

Similar Items

THE PROBLEMS OF BENEFICIAL DRUG SUPPORT
by: L. V. Shukil, et al.
Published: (2015-09-01)

Analysis of the drug prescription for obese patients in Moscow
by: V. S. Krysanova, et al.
Published: (2020-05-01)

ANALYSIS OF PHARMACEUTICAL SUPPORRT OF ONCOLOGICAL PATIENTS WITH NARCOTIC ANALGESICS IN THE OUTPATIENT SETTING IN NIZHNI NOVGOROD
by: S. V. Kononova, et al.
Published: (2015-10-01)

PROBLEMS AND PERSPECTIVES OF MEDICINAL PROVISION OF RUSSIAN AND ARMENIAN POPULATION
by: M. S. Koshel, et al.
Published: (2015-09-01)

Risk management role in system of Republic Sakha (Yakutia) medicinal maintenance
by: S. M. Tarabukina, et al.
Published: (2011-10-01)

Аудит закупок лекарственных средств для Московской области: 2008—2012 гг.
Published: (2018-06-01)

The ways of optimization of medicine supply in conditions of CATR Zelenogorsk
by: T. A. Barankina, et al.
Published: (2010-06-01)

Disseminated lung tuberculosis and tuberculosis meningoencephalitis after kidney transplantation
by: B. I. Yaremin, et al.
Published: (2018-09-01)

NEW SOFTWARE FOR PROCESSING DATA OF ENTIRE GENOME OF MYCOBACTERIUM TUBERCULOSIS
by: M. V. Sprindzhuk, et al.
Published: (2017-06-01)

Problems of pharmaceutical provision of population with hypolipidemic drugs: the case of the Volgograd region (the Russian Federation)
by: I. N. Tyurenkov, et al.
Published: (2020-05-01)

EVALUATION OF CHANGES IN TUBERCULOSIS EPIDEMIOLOGICAL RATES AMONG PRISONERS IN THE PENITENTIARY SYSTEM OF RUSSIA AND SMOLENSK REGION
by: N. A. Pavlyuchenkova, et al.
Published: (2016-12-01)

ANALYSIS OF THE IMPLEMENTATION OF THE FEDERAL ASSURANCE PROGRAM OF SUPPORTING BENEFICIARIES WITH INDISPENSABLE MEDICINAL PREPARATIONS IN THE SUBJECTS OF THE RUSSIAN FEDERATION
by: I. K. Petrukhina, et al.
Published: (2021-01-01)

Routing principles for patients with hereditary angioedema
by: A. N. Pampura, et al.
Published: (2021-07-01)

EFFICIENCY OF THE NEW MEDICATION OF FS-1 IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS
by: M. E. Kulmanov, et al.
Published: (2015-12-01)

Multicriteria analysis of the assortment of innovative drugs in oncohematology as a tool for supporting decision-making in the field of drug provision
by: S. V. Nedogoda, et al.
Published: (2018-07-01)

ABOUT THE RESULTS OF THE STUDY FOR SOME FACTORS WHICH INFLUENCE THE AWARENESS OF THE CITIZENS OF THE RUSSIAN FEDERATION ABOUT THEIR RIGHTS IN DRUG SUPPORT SYSTEM
by: T. V. Rejhtman
Published: (2015-12-01)

Provision of medicinal products to children with orphan diseases in the Rostov region
by: N. V. Kosiakova
Published: (2018-09-01)

The value of information service for the rational use of nootropics in preferential drug provision
by: E. V. Eliseeva, et al.
Published: (2020-09-01)

State of the Russian pharmaceutical industry at the present stage
by: E. N. Hoseva
Published: (2018-06-01)

METHODOLOGY OF THE DRUGS MARKET VOLUME MODELING ON THE EXAMPLE OF HEMOPHILIA A
by: N. B. Molchanova
Published: (2015-12-01)

A COMPARATIVE ANALYSIS OF THE ASSORTMENT OF DIFFERENT MEDICATION GROUPS USED IN THE CENTRAL REGIONAL HOSPITAL OF THE MUNICIPAL REGION AND THE REGIONAL HOSPITAL OF THE FEDERAL STATE-OPERATED HEALTHCARE AGENCY “MEDICAL AND SANITARY CENTER-23” (FKUZ MSCH-23) OF THE FEDERAL PENITENTIARY SERVICE (FSIN) OF RUSSIA
by: B. G. Bochkarev, et al.
Published: (2018-07-01)

CLUSTER ANALYSIS OF INTEGRATED “DRUG SUPPLY” CONCEPT
by: G. S. Barkaev, et al.
Published: (2022-07-01)

MODERN MODEL FORMATION OF DRUG PROVISION OF PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN KABARDINO-BALKARIA
by: A. A. Umirova, et al.
Published: (2019-07-01)

RESEARCH DESIGN SUBSTANTIATION ON MODERNIZATION OF POPULATION DRUG SUPPLY AT DIFFERENT STAGES OF HEALTHCARE DELIVERY
by: B. G. Bochkaryov, et al.
Published: (2015-09-01)

Methodological aspects in researching drug assistance to children with thyroid diseases
by: E E Loskutova, et al.
Published: (2013-12-01)

PROBLEMS OF FORMATION AND OPTIMIZATION OF RESOURCE PROVISION OF ENTERPRISES IN THE CONDITIONS OF FINANCIAL CONSTRAINTS
by: S. Demin, et al.
Published: (2016-03-01)

PROBLEMS OF FORMATION AND OPTIMIZATION OF RESOURCE PROVISION OF ENTERPRISES IN THE CONDITIONS OF FINANCIAL CONSTRAINTS
by: S. Demin, et al.
Published: (2019-02-01)

MODERN ASPECTS OF MEDICAL AND PHARMACEUTICAL AWARENESS OF HIV-INFECTED PATIENTS
by: Андрей Георгиевич Петров, et al.
Published: (2023-08-01)

ANALYSIS OF ANTIDIABETIC DRUGS ASSORTMENT REPRESENTED ON THE PHARMACEUTICAL MARKET OF SAINT PETERSBURG
by: Yu. V. Miroshnichenko, et al.
Published: (2015-10-01)

Screening for ТВ Infection. State of the Problem
by: E. A. Borodulina
Published: (2016-02-01)

Качество медицинской помощи глазами пациентов: итоги независимого онлайн-опроса. Часть II
by: Оксана Викторовна Забелина
Published: (2022-07-01)

Ways to increase patient compliance in the drugs preferential provision
by: E. V. Eliseeva, et al.
Published: (2020-01-01)

The role of information service in rational pharmacotherapy with thioctic acid in patients in Preferential Medicinal Providing
by: E. V. Eliseeva, et al.
Published: (2021-04-01)

INTERSTICIAL PNEUMONITIS, CAUSED BY PEGYLATED INTERFERON ALFA-2A IN A 4 MONTHS CHILD WITH GIGANTIC KAPOSI'S HAEMANGIOEPITHELIOM AND KASABACH – MERRIT PHENOMENON: A CASE REPORT
by: S. S. Postnikov, et al.
Published: (2022-05-01)

Drug-Induced Lung Disease (Organizing Pneumonia) Associated with Mesalazine
by: E. V. Smirnova, et al.
Published: (2022-02-01)

Automated plasmapheresis for management of hepatotoxic reactions to chemotherapy in pulmonary tuberculosis patients with multiple drug resistance including those with concurrent viral hepatitis
by: E. V. Vаniev, et al.
Published: (2018-11-01)

Issues of National Drug Security in Formation of a Reserve of Antibacterial Agents Intended to Eliminate Medical and Sanitary Consequences of Emergencies
by: L. Yu. Chernikova, et al.
Published: (2022-09-01)

STRATEGY OF PROVIDING FINANCING OF ORGANIZATIONS OF SMALL BUSINESS
by: N. I, Morozko
Published: (2017-10-01)

THE CHANGES IN THE STRUCTURE OF LOCALIZATIONS, PREVALENCE AND CLINICAL FORMS OF TUBERCULOSIS IN CHILDREN FROM 1985 TO 2015 IN OMSK REGION
by: N. I. PORKULEVICH, et al.
Published: (2017-10-01)

Prescription drug insurance requirement
by: M M Kurashov, et al.
Published: (2013-12-01)